Nonfunctional Adrenal Adenomas: Truth or Myth? Presentation and Treatment of 2 Patients

by Andreas G. Moraitis, MD
Published 2018-01-01

Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing’s Syndrome

by Andreas G. Moraitis, Richard J. Auchus
Published 2016-01-01

Adrenal Lymphangioma Masquerading as a Catecholamine Producing Tumor

by Israel Hodish, Lindsay Schmidt, Andreas G. Moraitis
Published 2015-01-01

Effects of Mifepristone on Nonalcoholic Fatty Liver Disease in a Patient with a Cortisol-Secreting Adrenal Adenoma

by Enzo Ragucci, Dat Nguyen, Michele Lamerson, Andreas G. Moraitis
Published 2017-01-01

Clinical and Hormonal Response to Mifepristone Therapy in 2 Patients with ACTH-Independent Cushing Syndrome

by Andreas G. Moraitis, MD, Richard J. Auchus, MD, PhD, FACE
Published 2015-01-01

Evaluation of FKBP5 as a cortisol activity biomarker in patients with ACTH-dependent Cushing syndrome

by Irina Bancos, Betul Ayse Hatipoglu, Kevin C.J. Yuen, Lakshmi Chandramohan, Sandeep Chaudhari, Andreas G. Moraitis
Published 2021-03-01

Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study

by Rosario Pivonello, Irina Bancos, Richard A. Feelders, Atil Y. Kargi, Janice M. Kerr, Murray B. Gordon, Cary N. Mariash, Massimo Terzolo, Noel Ellison, Andreas G. Moraitis
Published 2021-07-01